MNPR
MNPR
US61023L2079
Monopar Therapeutics Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue -- --
--
Cost of Revenue -- --
--
Gross Profit -- --
--
16.704.415 16.161.721
3.4%
Operating Income -16.704.415 -16.161.721
3.4%
Pretax Income -13.716.894 -15.586.419
12.0%
Net Income Common Stockholders -13.716.894 -15.586.419
12.0%
-- --
--
-- --
--
ende